Literature DB >> 32612208

Functional categories of immune inhibitory receptors.

Matevž Rumpret1,2, Julia Drylewicz1, Laura J E Ackermans1, José A M Borghans1, Ruslan Medzhitov3,4, Linde Meyaard5,6.   

Abstract

The human genome encodes more than 300 potential immune inhibitory receptors. The reason for this large number of receptors remains unclear. We suggest that inhibitory receptors operate as two distinct functional categories: receptors that control the signalling threshold for immune cell activation and receptors involved in the negative feedback of immune cell activation. These two categories have characteristic receptor expression patterns: 'threshold' receptors are expressed at steady state and their expression remains high or is downregulated upon activation, whereas 'negative feedback' receptors are induced upon immune cell activation. We use mathematical models to illustrate their possible modes of operation in different scenarios for different purposes. We discuss how this categorization may impact the choice of therapeutic targets for immunotherapy of malignant, infectious and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32612208     DOI: 10.1038/s41577-020-0352-z

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  50 in total

Review 1.  Homeostasis, inflammation, and disease susceptibility.

Authors:  Maya E Kotas; Ruslan Medzhitov
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

Review 2.  Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future.

Authors:  Marc Daëron; Sébastien Jaeger; Louis Du Pasquier; Eric Vivier
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

Review 3.  Immunoglobulin superfamily inhibitory receptors: from natural killer cells to antigen-presenting cells.

Authors:  M Colonna
Journal:  Res Immunol       Date:  1997 Mar-Apr

Review 4.  Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies.

Authors:  David J Byun; Jedd D Wolchok; Lynne M Rosenberg; Monica Girotra
Journal:  Nat Rev Endocrinol       Date:  2017-01-20       Impact factor: 43.330

Review 5.  Disease tolerance as a defense strategy.

Authors:  Ruslan Medzhitov; David S Schneider; Miguel P Soares
Journal:  Science       Date:  2012-02-24       Impact factor: 47.728

Review 6.  Do inhibitory immune receptors play a role in the etiology of autoimmune disease?

Authors:  Marloes J M Olde Nordkamp; Bobby P Koeleman; Linde Meyaard
Journal:  Clin Immunol       Date:  2013-11-19       Impact factor: 3.969

Review 7.  The genomic context of natural killer receptor extended gene families.

Authors:  J Trowsdale; R Barten; A Haude; C A Stewart; S Beck; M J Wilson
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

Review 8.  How do pathogens drive the evolution of paired receptors?

Authors:  Munir Akkaya; A Neil Barclay
Journal:  Eur J Immunol       Date:  2013-02       Impact factor: 5.532

Review 9.  Immune-related adverse events with immune checkpoint blockade: a comprehensive review.

Authors:  J M Michot; C Bigenwald; S Champiat; M Collins; F Carbonnel; S Postel-Vinay; A Berdelou; A Varga; R Bahleda; A Hollebecque; C Massard; A Fuerea; V Ribrag; A Gazzah; J P Armand; N Amellal; E Angevin; N Noel; C Boutros; C Mateus; C Robert; J C Soria; A Marabelle; O Lambotte
Journal:  Eur J Cancer       Date:  2016-01-05       Impact factor: 9.162

Review 10.  Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?

Authors:  Michiel van der Vlist; Jurgen Kuball; Timothy R D Radstake; Linde Meyaard
Journal:  Nat Rev Rheumatol       Date:  2016-08-19       Impact factor: 20.543

View more
  15 in total

Review 1.  New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells.

Authors:  Yanni Liu; Paul Nicklin; Yuan He
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

2.  NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division.

Authors:  Linda Borst; Marjolein Sluijter; Gregor Sturm; Pornpimol Charoentong; Saskia J Santegoets; Mandy van Gulijk; Marit J van Elsas; Christianne Groeneveldt; Nadine van Montfoort; Francesca Finotello; Zlatko Trajanoski; Szymon M Kiełbasa; Sjoerd H van der Burg; Thorbald van Hall
Journal:  Int J Cancer       Date:  2021-11-10       Impact factor: 7.316

3.  VISTA: A Target to Manage the Innate Cytokine Storm.

Authors:  Mohamed A ElTanbouly; Yanding Zhao; Evelien Schaafsma; Christopher M Burns; Rodwell Mabaera; Chao Cheng; Randolph J Noelle
Journal:  Front Immunol       Date:  2021-02-11       Impact factor: 7.561

4.  Editorial: The Role of Inhibitory Receptors in Inflammation and Cancer.

Authors:  Ali A Zarrin; Renato C Monteiro
Journal:  Front Immunol       Date:  2020-12-22       Impact factor: 7.561

5.  Identification of a novel conserved signaling motif in CD200 receptor required for its inhibitory function.

Authors:  Laura M Timmerman; J Fréderique de Graaf; Nikolaos Satravelas; Çan Kesmir; Linde Meyaard; Michiel van der Vlist
Journal:  PLoS One       Date:  2021-03-29       Impact factor: 3.240

6.  PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology.

Authors:  Zheng Chen; Mincheng Yu; Jiuliang Yan; Lei Guo; Bo Zhang; Shuang Liu; Jin Lei; Wentao Zhang; Binghai Zhou; Jie Gao; Zhangfu Yang; Xiaoqiang Li; Jian Zhou; Jia Fan; Qinghai Ye; Hui Li; Yongfeng Xu; Yongsheng Xiao
Journal:  Front Immunol       Date:  2021-03-24       Impact factor: 7.561

Review 7.  Inhibitory pattern recognition receptors.

Authors:  Matevž Rumpret; Helen J von Richthofen; Victor Peperzak; Linde Meyaard
Journal:  J Exp Med       Date:  2021-12-14       Impact factor: 17.579

8.  Identification and Characterization of the Amphioxus Lck and Its Associated Tyrosine Phosphorylation-Dependent Inhibitory LRR Receptor.

Authors:  Jiatao Zhou; Zhihui Xiao; Yanli Zhan; Xuemei Qu; Sisi Mou; Chong Deng; Tianxiang Zhang; Xin Lan; Shengfeng Huang; Yingqiu Li
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

9.  Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection.

Authors:  Narjes Saheb Sharif-Askari; Fatemeh Saheb Sharif-Askari; Bushra Mdkhana; Saba Al Heialy; Habiba S Alsafar; Rifat Hamoudi; Qutayba Hamid; Rabih Halwani
Journal:  Mol Ther Methods Clin Dev       Date:  2020-11-12       Impact factor: 6.698

Review 10.  DCision-making in tumors governs T cell anti-tumor immunity.

Authors:  Francesca Alfei; Ping-Chih Ho; Wan-Lin Lo
Journal:  Oncogene       Date:  2021-07-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.